1167.HK
Price:
$8.84
Market Cap:
$6.30B
Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company's lead drug development programs include two clinical-stage allosteric Src homology region 2 domain-containing phosphatase-2 (SHP2) inhibitors comprising JAB-3312 and JAB-3068 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also develops JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-634...[Read more]
Industry
Biotechnology
IPO Date
2020-12-21
Stock Exchange
HKSE
Ticker
1167.HK
According to Jacobio Pharmaceuticals Group Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -5.10%. This represents a change of -51.40% compared to the average of -10.49% of the last 4 quarters.
The mean historical ROE of Jacobio Pharmaceuticals Group Co., Ltd. over the last ten years is 16.41%. The current -5.10% ROE has changed -131.07% with respect to the historical average. Over the past ten years (40 quarters), 1167.HK's ROE was at its highest in in the December 2018 quarter at 78.23%. The ROE was at its lowest in in the December 2020 quarter at -39.34%.
Average
16.41%
Median
-18.40%
Minimum
-84.74%
Maximum
156.46%
Discovering the peaks and valleys of Jacobio Pharmaceuticals Group Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 57.60%
Maximum Annual ROE = 156.46%
Minimum Annual Increase = -160.16%
Minimum Annual ROE = -84.74%
| Year | ROE | Change |
|---|---|---|
| 2024 | -16.87% | -49.59% |
| 2023 | -33.46% | 15.39% |
| 2022 | -28.99% | 57.60% |
| 2021 | -18.40% | -78.29% |
| 2020 | -84.74% | -160.16% |
| 2019 | 140.86% | -9.97% |
The current ROE of Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-26.44%
5-year avg
-36.49%
10-year avg
16.41%
Jacobio Pharmaceuticals Group Co., Ltd.’s ROE is greater than Qyuns Therapeutics Co., Ltd. (-84.24%), less than Viva Biotech Holdings (4.48%), less than TYK Medicines, Inc (153.33%), greater than AIM Vaccine Co., Ltd. (-8.07%), greater than Jiangxi Rimag Group Co., Ltd. (-2.18%), greater than Ocumension Therapeutics (-6.71%), less than Medtide Inc. (0%), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (-49.89%), less than Tong Ren Tang Technologies Co. Ltd. (5.95%), greater than Yidu Tech Inc. (-3.00%),
| Company | ROE | Market cap |
|---|---|---|
| -84.24% | $4.27B | |
| 4.48% | $4.11B | |
| 153.33% | $4.93B | |
| -8.07% | $4.17B | |
| -2.18% | $3.39B | |
| -6.71% | $6.54B | |
| 0% | $4.04B | |
| -49.89% | $2.46B | |
| 5.95% | $5.75B | |
| -3.00% | $5.33B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jacobio Pharmaceuticals Group Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Jacobio Pharmaceuticals Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Jacobio Pharmaceuticals Group Co., Ltd.'s ROE?
How is the ROE calculated for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the highest ROE for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the 3-year average ROE for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
What is the 5-year average ROE for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)?
How does the current ROE for Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK) compare to its historical average?